Skip to content
Precision for Medicine
Breaking News

Precision Wins Fierce CRO Award for Innovative Solutions in Drug Development

Precision for Medicine Wins Fierce CRO Award for Innovative Solutions in Drug Development

CRO Winner Badge@2x

BETHESDA, MD., June 18, 2025   

Precision for Medicine, a leading next-generation provider of drug research and development services, today announced it has won the Fierce CRO Award for Innovative Solutions in Drug Development. This award recognizes clinical research organizations (CROs) that have developed or applied innovative methodologies or technologies to advance drug development processes, improving efficiency and effectiveness. Specifically, Precision for Medicine is being recognized for best-in-class centralized monitoring and data management via an agile, collaborative approach to accelerating clinical outcomes for people with cancer and rare disease.

Because today’s oncology trials generate vast amounts of data due to complex clinical assessments, biomarker data, imaging data, and patient demographics, Precision’s Centralized Monitoring team deploys a unique data management methodology. The approach enables sponsors to manage trial data – and prepare it for regulatory scrutiny – in a manner that is clean, compliant and can be used confidently in regulatory submissions.

“We are honored to receive this award acknowledging our unique ability to collaborate with sites and sponsors to build solutions that meet rapidly evolving cancer trial models as well as successfully complete complex rescue trials,” said Simon Fleming, Executive Vice President, Clinical and Data Operations, Precision for Medicine. “Our Centralized Monitoring team is not only defined by its cutting-edge solutions but also by the depth of its therapeutic experience. Because our oncology expertise is woven into the way we operate, we can bring a unique point of view and fresh insights that deliver on our clients’ needs. When we look at the data, we go beyond basic data verification; we have the clinical indication and tumor type fluency to determine whether the data makes clinical sense.”

Precision’s award-winning Centralized Monitoring team includes members not just with oncology research backgrounds, including solid tumors and hematologic conditions, but also nursing experience, data analytics and other specialties that contribute diverse perspectives and abilities to clients’ programs. This team is purpose-built to deliver high-quality data reviews for small and mid-sized biopharmaceutical companies.

“As a next generation CRO, we are committed to shifting the development paradigm and breaking down those barriers that impede speed of clinical outcomes. Because we are a right-sized CRO for innovators, with low turnover for project consistency, our clients can rely on us to remove silos and streamline processes to accelerate development timelines,” said Sofia Baig, President, Precision for Medicine. “This award is validation that our collaborative approach is adding value for clients, and ultimately, for patients."

The Fierce CRO Awards celebrate exceptional achievements and innovations by CROs. These awards honor CROs that have demonstrated outstanding performance, innovation, and leadership in delivering high-quality research and development services. By recognizing the excellence of CROs, the awards aim to highlight the critical role they play in advancing life sciences research and improving patient outcomes.

 

About Precision for Medicine
Precision for Medicine is the first biomarker-driven clinical research and development services organization supporting life sciences companies in the use of biomarkers essential to targeting patient treatments more precisely and effectively. Precision applies a transformational approach to clinical research that integrates clinical trial design and execution with deep scientific knowledge, laboratory expertise and advanced data intelligence. This convergence is driving faster clinical development and approval. Precision for Medicine is part of Precision Medicine Group, with 3,500 people in 40 locations globally across North America, Europe and Asia-Pacific. For more information, visit PrecisionForMedicine.com.

Contact
Marc Goldstein
Executive Director, Marketing, Clinical Solutions
Precision for Medicine

marc.goldstein@precisionformedicine.com